coumarin has been researched along with EHS Tumor in 1 studies
2H-chromen-2-one: coumarin derivative
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patra, AR | 1 |
| Roy, SS | 1 |
| Basu, A | 1 |
| Bhuniya, A | 1 |
| Bhattacharjee, A | 1 |
| Hajra, S | 1 |
| Sk, UH | 1 |
| Baral, R | 1 |
| Bhattacharya, S | 1 |
1 other study available for coumarin and EHS Tumor
| Article | Year |
|---|---|
Design and synthesis of coumarin-based organoselenium as a new hit for myeloprotection and synergistic therapeutic efficacy in adjuvant therapy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Proliferation; Chemotherapy, Adjuvant; | 2018 |